UNLIMITED TURBO SHORT - FRESENIUS MEDICAL CARE Stock

Certificat

DE000PN2DQ19

Delayed Deutsche Boerse AG 02:20:53 2024-06-25 EDT
1.95 EUR 0.00% Intraday chart for UNLIMITED TURBO SHORT - FRESENIUS MEDICAL CARE
Current month+18.90%
1 month+17.47%
Date Price Change
24-06-25 1.95 0.00%
24-06-24 1.95 -2.01%
24-06-21 1.99 +4.19%
24-06-20 1.91 -1.55%
24-06-19 1.94 +2.65%

Delayed Quote Deutsche Boerse AG

Last update June 25, 2024 at 02:20 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN2DQ1
ISINDE000PN2DQ19
Date issued 2023-04-21
Strike 55.48
Maturity Unlimited
Parity 10 : 1
Emission price 2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.62
Lowest since issue 0.75
Spread 0.02
Spread %1.02%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.35 EUR
Average target price
39.97 EUR
Spread / Average Target
+9.97%
Consensus